Saturday, October 15, 2016 10:06:05 AM
And now IFLM is at .0002 and will likely go back to no bid.
It doesn't matter if a company claims to have found a cure for the common cold when there are multiple toxic convertible debenture notes to be paid.
The noteholders don't care, they only want money, money, money.
The noteholders love PUMPS when they can sell their .00005 shares for .0016.
And not one shred of contrition or embarrassment when the PUMP suckered the .0016 buyers. Not one shred!!!!!!
To bite the worm of incite is to bite the HOOK of the antagonist . They win .
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM